141st APHA Annual Meeting

In This section

287544
Diabetes among minority populations in New York City

Tuesday, November 5, 2013

Laura Wyatt, MPH , Center for the Study of Asian American Health, Institute of Community Health and Research, NYU School of Medicine, New York, NY
Charmaine Ruddock, MS , Bronx Health REACH, New York, NY
Simona Kwon, DrPH, MPH , Center for the Study of Asian American Health, New York University School of Medicine, New York, NY
Carlos Devia, MA , Bronx Health REACH- NY CEED, Institute for Family Health, New York, NY
Ashley Fox, PhD, MA , Department of Health Evidence and Policy, Mount Sinai School of Medicine, New York, NY
Carol R. Horowitz, MD, MPH , Department of Health Evidence and Policy, Mount Sinai School of Medicine, New York, NY
Nadia Islam, PhD , Center for the Study of Asian American Health, NYU Institute of Community Health and Research, NYU School of Medicine, New York, NY
Chau Trinh-Shevrin, DrPH , Center for the Study of Asian American Health, Institute of Community Health and Research, NYU School of Medicine, New York, NY
Background/Significance: Disparities in diabetes prevalence exist, especially in ethnic minority communities. Information on diabetes prevalence and risk factors was collected using 3 years of the REACH U.S. Risk Factor Survey, which over-sampled 3 ethnic minority populations living in predominately ethnic enclaves in New York City (NYC). Methods: Survey data targeting minority subgroups from 2009 to 2011 yielded approximately 3215 Asian Americans, 2410 non-Hispanic African Americans, and 3607 Hispanics. Demographic and health variables were run by subgroup, including diabetes prevalence rates (not including gestational). Bivariate analyses determined factors related to a diabetes diagnosis by subgroup, and logistic regression predicted factors related to a diabetes outcome, while adjusting for all other variables. Results: Unweighted measurements found diabetes prevalence to be 18.7% among non-Hispanic African Americans, 20.7% among Hispanics, and 13.1% among Asians. Asian Indians had the highest diabetes prevalence, of 21.5%. Further weighted analyses will examine diabetes prevalence in greater detail among ethnic subgroups, including mixed races, as well as factors related to diabetes in the larger subgroups, including neighborhood. Among diabetics, diabetes management will be examined, including self-management (checking blood sugar and feet) and management through a health professional (doctor visits, checking HbA1c, and eye exams). Discussion/Conclusions: Diabetes in the non-Hispanic African American and Hispanic communities were higher than in the aggregated Asian communities, although rates among Asian Indians were the highest. All rates are higher than estimates reported by the latest health department's NYC Community Health Survey. This information will inform researchers addressing health disparities faced by ethnic minority groups living in ethnic enclaves.

Learning Areas:
Assessment of individual and community needs for health education
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Epidemiology
Planning of health education strategies, interventions, and programs
Public health or related research

Learning Objectives:
Describe the prevalence of diabetes among Asian Americans, Hispanics, and African Americans living in predominantly ethnic enclaves in New York City, and compare the prevalence to published New York City data Identify factors associated with diabetes in each of the ethnic minority populations

Keywords: Diabetes, Minority Research

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have an MPH in public health, and I perform analyses and assist with the dissemination of study findings within the Center of the Study of Asian American Health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.